First American Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
18,800
-2,603
| -12% | -$180K | 0.1% | 126 |
|
|
2025
Q1 | $1.49M | Sell |
21,403
-22,145
| -51% | -$1.54M | 0.14% | 115 |
|
|
2024
Q4 | $3.75M | Buy |
43,548
+119
| +0.3% | +$10.2K | 0.37% | 81 |
|
|
2024
Q3 | $5.17M | Sell |
43,429
-9,827
| -18% | -$1.17M | 0.51% | 64 |
|
|
2024
Q2 | $7.6M | Buy |
53,256
+534
| +1% | +$76.2K | 0.76% | 46 |
|
|
2024
Q1 | $6.77M | Buy |
52,722
+2,493
| +5% | +$320K | 0.71% | 52 |
|
|
2023
Q4 | $5.2M | Buy |
50,229
+2,868
| +6% | +$297K | 0.64% | 59 |
|
|
2023
Q3 | $4.31M | Sell |
47,361
-23,007
| -33% | -$2.09M | 0.61% | 63 |
|
|
2023
Q2 | $5.69M | Buy |
70,368
+644
| +0.9% | +$52.1K | 0.78% | 56 |
|
|
2023
Q1 | $5.55M | Sell |
69,724
-37,432
| -35% | -$2.98M | 0.82% | 47 |
|
|
2022
Q4 | $7.25M | Buy |
107,156
+2,990
| +3% | +$202K | 1.12% | 32 |
|
|
2022
Q3 | $5.19M | Buy |
104,166
+1,262
| +1% | +$62.9K | 0.87% | 45 |
|
|
2022
Q2 | $5.73M | Buy |
102,904
+4,008
| +4% | +$223K | 0.91% | 45 |
|
|
2022
Q1 | $5.49M | Buy |
98,896
+3,852
| +4% | +$214K | 0.76% | 54 |
|
|
2021
Q4 | $5.32M | Sell |
95,044
-43,118
| -31% | -$2.41M | 0.73% | 49 |
|
|
2021
Q3 | $6.63M | Buy |
138,162
+8,220
| +6% | +$395K | 1% | 34 |
|
|
2021
Q2 | $5.44M | Buy |
129,942
+7,028
| +6% | +$294K | 0.85% | 45 |
|
|
2021
Q1 | $4.14M | Buy |
+122,914
| New | +$4.14M | 0.65% | 57 |
|